RepliCel Life Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. RepliCel Life Sciences's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $353,735. The net income raised on -$311,734 and profit margin reached -88%. Total operating expenses were $1,739,990.

Profit Margin

RepliCel Life Sciences Inc. (TSX:RP.V): Profit margin
2014 0 -5.19M
2015 0 -5.04M
2016 0 -4.27M
2017 0 -6.01M
2018 121.11K -2.76M -2286.34%
2019 353.73K -3.00M -849.27%
2020 353.73K -1.58M -446.74%
2021 353.73K -4.07M -1151.52%
2022 353.73K -743.22K -210.11%
2023 353.73K -311.73K -88.13%

RP.V Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
353.73K353.73K353.73K353.73K353.73K121.11K0000
Cost of revenue
0000004.15K5.78K6.97K0
Gross profit
353.73K353.73K353.73K353.73K353.73K121.11K-4.15K-5.78K-6.97K0
Operating exp.
Research and development
526.43K623.96K1.14M819.40K2.19M709.26K2.54M1.11M2.31M1.94M
Selling and marketing
0000000000
Total operating expenses
1.73M1.74M2.65M1.68M3.28M2.86M5.99M4.28M5.04M5.21M
Operating income
-1.38M-191.43K-3.17M-1.14M-2.88M-2.70M-5.99M-4.28M-5.04M-5.21M
Other income (expenses), net
1.07M656.12K-1.76M-229.91K-77.31K-29.81K-22.41K16.33K2.91K12.20K
Income before tax
-311.73K-743.22K-4.07M-1.58M-3.00M-2.76M-6.01M-4.27M-5.04M-5.19M
Income tax expense
01.20M-867.89K183.53K44.02K29.78K22.41K-16.33K-2.91K-12.20K
Net income
-311.73K-743.22K-4.07M-1.58M-3.00M-2.76M-6.01M-4.27M-5.04M-5.19M
Earnings per share
Basic EPS
-0.00-0.01-0.13-0.05-0.12-0.13-0.32-0.54-0.89-1.02
Diluted EPS
-0.00-0.01-0.13-0.05-0.12-0.13-0.32-0.54-0.89-1.02